Sara D'andrea

Aviano, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

CDK12/13 inhibition overcomes platinum resistance by impairing RNA metabolism.

CDK12/13 inhibition overcomes platinum resistance by impairing RNA metabolism.

Journal: Signal transduction and targeted therapy

Published: January 20, 2026

Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience.

Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience.

Journal: The journal of liquid biopsy

Published: July 04, 2025

USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activity.

USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activity.

Journal: Science advances

Published: November 13, 2024

Author Correction: Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer.

Author Correction: Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer.

Journal: EMBO molecular medicine

Published: July 12, 2024

A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors.

A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors.

Journal: The Journal of pathology

Published: May 08, 2024

Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice.

Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice.

Journal: NPJ breast cancer

Published: July 10, 2023

Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer.

Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer.

Journal: EMBO molecular medicine

Published: July 03, 2023

Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.

Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.

Journal: Cancer communications (London, England)

Published: December 12, 2022

CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.

CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.

Journal: The Journal of pathology

Published: May 22, 2020

Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells.

Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells.

Journal: Oncogene

Published: December 30, 2019

Identification and Characterization of a New Platinum-Induced TP53 Mutation in MDAH Ovarian Cancer Cells.

Identification and Characterization of a New Platinum-Induced TP53 Mutation in MDAH Ovarian Cancer Cells.

Journal: Cells

Published: October 28, 2019

Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity.

Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity.

Journal: Oncogene

Published: September 27, 2019

Showing 1-12 of 26

Last Updated: 09/26/2026